PRO-C3 determined active fibrogenesis is a predictor of liver-related outcomes in patients with chronic hepatitis C

被引:0
|
作者
Skovgaard, Emilie [1 ,2 ]
Moller, Thomas [1 ,3 ]
Karsdal, Morten [1 ]
Leeming, Diana [1 ]
Patel, Keyur [4 ]
机构
[1] Nord Biosci AS, Herlev, Denmark
[2] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Biomed Sci, Copenhagen N, Denmark
[4] Univ Hlth Network, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-370
引用
收藏
页码:S737 / S737
页数:1
相关论文
共 50 条
  • [1] PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease
    Nielsen, Mette J.
    Dolman, Grace E.
    Harris, Rebecca
    Frederiksen, Peder
    Chalmers, Jane
    Grove, Jane I.
    Irving, William L.
    Karsdal, Morten A.
    Patel, Keyur
    Leeming, Diana Julie
    Guha, Indra Neil
    JHEP REPORTS, 2023, 5 (06)
  • [2] Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease
    Johansen, Stine
    Israelsen, Mads F.
    Villesen, Ida
    Torp, Nikolaj J.
    Nielsen, Mette
    Kjaergaard, Maria P.
    Lindvig, Katrine D.
    Hansen, Camilla
    Andersen, Peter N.
    Rasmussen, Ditlev
    Detlefsen, Sonke J.
    Leeming, Diana
    Thiele, Maja
    Karsdal, Morten
    Krag, Aleksander
    Anastasiadou, Ema
    Arumugam, Manimozhian
    Bork, Peer
    Hansen, Torben
    Henrar, Roland
    Israelsen, Hans
    Karsdal, Morten
    Legido-Quigley, Cristina
    Melberg, Hans Olav
    Thiele, Maja
    Trebicka, Jonel
    Krag, Aleksander
    Mann, Mathias
    Matthijnssens, Jelle
    LIVER INTERNATIONAL, 2023, 43 (07) : 1486 - 1496
  • [3] PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C
    Hansen, Janne Fuglsang
    Nielsen, Mette Juul
    Nystrom, Kristina
    Leeming, Diana Julie
    Lagging, Martin
    Norkrans, Gunnar
    Christensen, Peer Brehm
    Karsdal, Morten
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (01) : 83 - 87
  • [4] Predictors of liver-related complications in patients with chronic hepatitis C
    Chitturi, S
    George, J
    ANNALS OF MEDICINE, 2000, 32 (09) : 588 - 591
  • [5] Liver stiffness measurements for the prediction of liver-related outcomes in chronic hepatitis C patients after viral elimination
    Liu, Yen-Chun
    Jeng, Rachel Wen-Juei
    Cheng, Ya-Ting
    Hsieh, Yi-Chung
    Chen, Yi-Cheng
    Lin, Chun-yen
    Chien, Rong-Nan
    Dar-In, Tai
    Sheen, I-Shyan
    JOURNAL OF HEPATOLOGY, 2021, 75 : S788 - S788
  • [6] Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery
    Lassen, Pierre Bel
    Nori, Nicole
    Bedossa, Pierre
    Genser, Laurent
    Aron-Wisnewsky, Judith
    Poitou, Christine
    Surabattula, Rambabu
    Nielsen, Mette Juul
    Karsdal, Morten Asser
    Leeming, Diana Julie
    Schuppan, Detlef
    Clement, Karine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04): : E1356 - E1366
  • [7] Serum models accurately predict liver-related clinical outcomes in chronic hepatitis C
    Huang, Yi
    Adams, Leon A.
    MacQuillan, Gerry
    Speers, David
    Joseph, John
    Bulsara, Max K.
    Jeffrey, Gary P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (10) : 1736 - 1741
  • [8] PRO-C3 as a Biomarker for Liver Fibrosis
    Kahl, S.
    DIABETOLOGE, 2021, 17 (07): : 758 - 760
  • [9] Liver-related effects of chronic hepatitis C antiviral treatment
    Laursen, Tea L.
    Sandahl, Thomas D.
    Kazankov, Konstantin
    George, Jacob
    Gronbaek, Henning
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (22) : 2931 - 2947
  • [10] Liver-related effects of chronic hepatitis C antiviral treatment
    Tea L Laursen
    Thomas D Sandahl
    Konstantin Kazankov
    Jacob George
    Henning Gr?nb?k
    World Journal of Gastroenterology, 2020, 26 (22) : 2931 - 2947